Esomeprazole Magnesium for Delayed-Release Oral Suspension 40mg, packaged in unit dose packets, Rx only, Manufactured by: Cipla Ltd., Kurkumbh, India, Manufactured for: Cipla USA, Inc. 10 Independence Boulevard, Suite 300 Warren, NJ 07059 NDC 69097-529-34
Published January 6, 2021 · Recall initiated: December 17, 2020
Summary
FDA records drug Class II recall D-0183-2021, published January 6, 2021 and initiated December 17, 2020. Recalling firm: CIPLA; Status: Terminated; Reported quantity: 6,491 packets; Lot: Lot #: KA00415, KA00416, Exp 11/2021. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Cross- contamination with other products: The excipient, Crospovidone, NF is contaminated with theophylline
What to do
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Get an email if ESOMEPRAZOLE MAGNESIUM has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- ESOMEPRAZOLE MAGNESIUM
- Manufacturer
- CIPLA
- Distributor
- U.S.A. Nationwide
- Lot
- Lot #: KA00415, KA00416, Exp 11/2021
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAEsomeprazole Magnesium for Delayed-Release Oral Suspension, 40 mg, 30-count Single-Dose Packets per carton, RxMay 28, 2025
- FDAEsomeprazole Magnesium for Delayed-Release Oral Suspension, 20 mg, 30-count single dose packets per carton, RxMay 28, 2025
- FDAEsomeprazole Magnesium for Delayed-Release Oral Suspension 40 mg, 30 Single-Dose Packets, Rx Only,December 11, 2024
- FDAEsomeprazole Magnesium Delayed-Release Capsules, USP 20mg, Packaged as (a) 30-count bottle, NDC 68462-390-30;November 29, 2023
- FDAEsomeprazole Magnesium for Delayed-Release Oral Suspension 20mg, packaged in unit dose packets, Rx only,January 6, 2021
- FDAKetorolac Tromethamine Injection, USP, 60 mg per 2 mL (30 mg per mL), packaged in 2 mL Single Dose Vial, RxJanuary 6, 2021
Questions about this recall
Was Esomeprazole Magnesium for Delayed-Release Oral Suspension 40mg, packaged in unit dose packets, Rx only, Manufactured by: Cipla Ltd., Kurkumbh, India, Manufactured for: Cipla USA, Inc. 10 Independence Boulevard, Suite 300 Warren, NJ 07059 NDC 69097-529-34 recalled?
Yes. FDA published recall D-0183-2021 on January 6, 2021. Reported hazard: Cross- contamination with other products: The excipient, Crospovidone, NF is contaminated with theophylline
What should I do if I have this product?
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: ESOMEPRAZOLE MAGNESIUM.